With a revenue increase of 55.51% in the first quarter 2026, year on year to cumulative value of $754 million, Kiniksa Pharmaceuticals International Plc's revenue per employee grew on a trailing twelve months basis to $ 2,060,232, this marks a new company high.
Within the Healthcare sector Employees of 3 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 125, from total ranking in previous quarter at 365. Kiniksa Pharmaceuticals International Plc has 366 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KNSA Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	55.51 %	64.95 %	61.17 %	44.34 %	72.54 %
Sales per Employee (TTM) $	2,060,232	1,851,268	1,633,806	1,446,262	1,314,661
KNSA's Total Ranking	# 125	# 365	# 189	# 396	# 320
Seq. Revenue Change	6.01 %	11.76 %	15.34 %	13.8 %	12.44 %

KNSA Company Profile >> Back to KNSA Efficiency Comparisons >> Compare KNSA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 1
Healthcare Sector	# 4
Overall Market	# 125

Revenue per Employee Statistics
High	Average	Low
$ 2,060,232	$ 977,540	$ 193,260
(Mar 31 2026)		(Mar 31 2022)

Financial Statements
Kiniksa Pharmaceuticals International Plc's Revenue MRQ	$ 214 Millions	Visit KNSA's Income Statement
Kiniksa Pharmaceuticals International Plc's Revenues TTM	$ 754 Millions	Visit KNSA's aggregate revenue growth
What are KNSA's Sales?		Visit KNSA's Sales by Segment

Other Ratios
Kiniksa Pharmaceuticals International Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KNSA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KNSA's Competitors
Revenue per Employee for KNSA's Suppliers
Revenue per Employee for KNSA's Customers

You may also want to know
KNSA's Sales Growth Rates	KNSA's Pe Price to earnings ratio	KNSA's Receivables Turnover Ratio	KNSA's Stock Quote
KNSA's Net Income Growth Rates	KNSA's Ps Price to Sales ratio	KNSA's Sales per Employee	KNSA's Asset Turnover Ratio
KNSA's Net Margin	KNSA's Pb Price to Book ratio	KNSA's Financial Strength Ratios	KNSA's Dividend Payout Ratio

Date modified: 2026-06-22T16:30:42+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Halozyme Therapeutics Inc	3,566,094.56	$ 1,508.458 Million	423
Amgen Inc	3,489,923.08	$ 45,369.000 Million	13,000
Aytu Biopharma Inc	3,478,937.50	$ 55.663 Million	16
Xoma Royalty Corporation	3,468,214.29	$ 48.555 Million	14
Illumina Inc	3,432,031.25	$ 4,393.000 Million	1,280
Therapeuticsmd Inc	3,353,000.00	$ 3.353 Million	1
Nuvation Bio Inc	3,305,139.53	$ 142.121 Million	43
Catalyst Pharmaceuticals Inc	3,279,989.01	$ 596.958 Million	182
Harmony Biosciences Holdings inc	3,069,102.39	$ 899.247 Million	293
Sarepta Therapeutics Inc	2,615,789.22	$ 2,184.184 Million	835
Innoviva Inc	2,479,150.94	$ 394.185 Million	159
Spero Therapeutics Inc	2,447,440.00	$ 61.186 Million	25
Aurinia Pharmaceuticals Inc	2,330,429.69	$ 298.295 Million	128
United Therapeutics Corporation	2,264,142.86	$ 3,169.800 Million	1,400
Elite Pharmaceuticals Inc	2,261,542.74	$ 147.000 Million	65
Anaptysbio Inc	2,234,500.00	$ 232.388 Million	104
Exelixis Inc	2,071,047.08	$ 2,375.491 Million	1,147
Kiniksa Pharmaceuticals International Plc	2,060,232.24	$ 754.045 Million	366
Cormedix Inc	2,040,572.14	$ 389.749 Million	191
Biocryst Pharmaceuticals Inc	2,036,128.74	$ 885.716 Million	435
Eton Pharmaceuticals Inc	1,968,500.00	$ 86.614 Million	44
Assertio Holdings inc	1,927,509.43	$ 102.158 Million	53
Siga Technologies Inc	1,913,809.53	$ 93.777 Million	49
Prestige Consumer Healthcare Inc	1,909,785.96	$ 1,088.578 Million	570
Zevra Therapeutics Inc	1,886,442.62	$ 115.073 Million	61
Incyte Corporation	1,885,028.13	$ 5,361.020 Million	2,844
Privia Health Group Inc	1,832,456.77	$ 2,246.592 Million	1,226
Tg Therapeutics Inc	1,755,260.65	$ 700.349 Million	399
Gilead Sciences Inc	1,749,176.47	$ 29,736.000 Million	17,000
Collegium Pharmaceutical Inc	1,747,635.93	$ 739.250 Million	423

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.